Atherosclerotic Cardiovascular Disease in Gulf War Veterans in Relation to Deployment Exposures
- PMID: 40616710
- PMCID: PMC12310855
- DOI: 10.1007/s12012-025-10013-7
Atherosclerotic Cardiovascular Disease in Gulf War Veterans in Relation to Deployment Exposures
Abstract
Many 1990-1991 Gulf War Veterans (GWVs) were exposed to toxicants and environmental hazards during deployment, including oil well fire smoke, chemical/biological agents, pyridostigmine bromide (PB) pills, and pesticides. Multiple constituents of smoke are associated with increased risk for atherosclerotic cardiovascular diseases (ASCVD), and other toxic exposures have been associated with autonomic and lipid dysfunction. We used data from the Gulf War Era Cohort and Biorepository Study of veterans deployed to Gulf War in 1990-1991 (n = 942). We evaluated the association of deployment exposures (no, yes (1-6 days), (7-30 days), (31 + days), and not sure) with clinical risk factors (hypertension, diabetes, high cholesterol) and ASCVD using multivariable logistic regression. We adjusted for all clinical risk factors in the models to test the association of military exposures and ASCVD. We found that 7-30 days exposure to oil well fire smoke (OR: 2.95, CI: 1.40, 6.19), PB pills (OR: 2.37, CI: 1.06, 5.32), and chemical/biological agents (OR: 3.60, CI: 1.04, 12.51) were associated with ASCVD. Exposure to chemical/biological agents for 7-30 days was also associated with hypertension (OR: 4.18, CI: 1.48, 11.86) and for 31 + days was associated with ASCVD (OR: 4.24, CI:1.20, 14.94). The associations between oil well fire smoke and chemical/biological agents with ASCVD remained significant in models adjusting for clinical risk factors. For GWVs, exposure to oil well fire smoke, chemical/biological agents, and PB pills were associated with ASCVD. These exposures may represent population-specific risk enhancers for ASCVD and may be considered in individualized clinical risk assessment.
Keywords: ASCVD; Diabetes; Gulf war veterans; High cholesterol; Hypertension; Military exposures.
© 2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
Declarations. Competing Interest: Dr. Morgan reports funding support from NIH (NIA), U.S. Department of Veteran Affairs and the Episcopal Health Foundation. Dr. Nambi reports stock options in Insera Therapeutics, research support from Abbott Labs, and site co-investigator role on a study sponsored by Ionis. The remaining authors have nothing to disclose.
Similar articles
-
Association of deployment characteristics and exposures with persistent ill health among 1990-1991 Gulf War veterans in the VA Million Veteran Program.Environ Health. 2024 Oct 25;23(1):92. doi: 10.1186/s12940-024-01118-7. Environ Health. 2024. PMID: 39456027 Free PMC article.
-
Genetic association between the APOE ε4 allele, toxicant exposures and Gulf war illness diagnosis.Environ Health. 2023 Jul 6;22(1):51. doi: 10.1186/s12940-023-01002-w. Environ Health. 2023. PMID: 37415220 Free PMC article.
-
Longitudinal Assessment of Ocular Biomarkers in Individuals With Gulf War Illness Symptoms.Mil Med. 2025 Jun 30;190(7-8):e1670-e1678. doi: 10.1093/milmed/usae457. Mil Med. 2025. PMID: 39361156 Free PMC article.
-
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD009868. doi: 10.1002/14651858.CD009868.pub3. Cochrane Database Syst Rev. 2017. PMID: 28263370 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Steele, L. (2000). Prevalence and patterns of Gulf War illness in Kansas veterans: Association of symptoms with characteristics of person, place, and time of military service. American Journal of Epidemiology,152(10), 992–1002. 10.1093/aje/152.10.992 - PubMed
-
- Fukuda, K., Nisenbaum, R., Stewart, G., Thompson, W. W., Robin, L., Washko, R. M., Noah, D. L., Barrett, D. H., Randall, B., Herwaldt, B. L., Mawle, A. C., & Reeves, W. C. (1998). Chronic multisymptom illness affecting air force veterans of the Gulf War. JAMA,280(11), 981–988. 10.1001/jama.280.11.981 - PubMed
-
- Ahmed, S. T., Steele, L., Richardson, P., Nadkarni, S., Bandi, S., Rowneki, M., Sims, K. L., Vahey, J., Gifford, E. J., Boyle, S. H., Nguyen, T. H., Djosta, A. N., White, D. L., Hauser, E. R., Chandler, H., Yamal, J. M., & Helmer, D. A. (2022). Association of Gulf War illness-related symptoms with military exposures among 1990–1991 Gulf War veterans evaluated at the war-related illness and injury study center (WRIISC). Brain Sciences,12(3), 321. 10.3390/brainsci12030321 - PMC - PubMed
-
- Research Advisory Committee Report on Gulf War Illnesses. Gulf War Illness and the Health of Gulf War Veterans: Research Update and Recommendations, 2009–2013. U.S. Government Printing Office Washington, D.C. 2014. Accessed April 2022
-
- Institute of Medicine (US) Committee on Gulf War and Health: Health Effects of Serving in the Gulf War, Update 2009. “Gulf War and Heath: Volume 8: Update of Health Effects of Serving in the Gulf War”. Washington (DC): National Academics Press (US); 2010 Appendix A, Cholinesterase Inhibitors and Multi symptom Illness. Accessed May 2022
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical